bacterial topoisomerase inhibitors (Merck Research Laboratories/WuXi AppTec/Kyorin Pharmaceutical)

N/A

Report date: 2025/03/17 09:43:03
NME

Base Information

Drug Namebacterial topoisomerase inhibitors (Merck Research Laboratories/WuXi AppTec/Kyorin Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Pharmaceutical Co LtdMerck Research LaboratoriesWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A